SCOPUS 정보 검색 플랫폼

Journal of Neurology

Volumn 258, Issue 12, 2011, Pages 2284-2285

BAFF serum levels in myasthenia gravis: Effects of therapy

(4) Scuderi, Flavia a Alboini, Paolo E a Bartoccioni, Emanuela a Evoli, Amelia a

a CATHOLIC UNIVERSITY (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THERAPY EFFECT; THYMECTOMY; THYMOMA; THYMUS HYPERPLASIA;

ADOLESCENT; ADULT; AGED; B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; THYMECTOMY; YOUNG ADULT;

EID: 83255187854 PISSN: 03405354 EISSN: 14321459 Source Type: Journal
DOI: 10.1007/s00415-011-6092-z Document Type: Letter

Times cited : (17)

References (10)

1
- 0033532634
- BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
- DOI 10.1084/jem.189.11.1747
- Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189: 1747-1756 (Pubitemid 29272691)
- (1999) Journal of Experimental Medicine , vol.189 , Issue.11 , pp. 1747-1756
- Schneider, P.¹ Mackay, F.² Steiner, V.³ Hofmann, K.⁴ Bodmer, J.-L.⁵ Holler, N.⁶ Ambrose, C.⁷ Lawton, P.⁸ Bixler, S.⁹ Acha-Orbea, H.¹⁰ Valmori, D.¹¹ Romero, P.¹² Werner-Favre, C.¹³ Zubler, R.H.¹⁴ Browning, J.L.¹⁵ Tschopp, J.¹⁶

2
- 0036498694
- The role of BAFF in B-cell maturation, T-cell activation and autoimmunity
- Mackay F, Mackay CR (2002) The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol 23:113-115
- (2002) Trends Immunol , vol.23 , pp. 113-115
- MacKay, F.¹ MacKay, C.R.²

3
- 70349658717
- BAFF: A local and systemic target in autoimmune diseases
- Moisini I, Davidson A (2009) BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 158:155-163
- (2009) Clin Exp Immunol , vol.158 , pp. 155-163
- Moisini, I.¹ Davidson, A.²

4
- 0035973305
- Myasthenia gravis
- DOI 10.1016/S0140-6736(00)05186-2
- Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia gravis. Lancet 357:2122-2128 (Pubitemid 32607461)
- (2001) Lancet , vol.357 , Issue.9274 , pp. 2122-2128
- Vincent, A.¹ Palace, J.² Hilton-Jones, D.³

5
- 33748283337
- The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis
- DOI 10.1016/j.jneuroim.2006.05.023, PII S0165572806002074
- Thangarajh M, Masterman T, Helgeland L, Rot U, Jonsson MV, Eide GE, Pirskanen R, Hillert J, Jonsson R (2006) The thymus is a source of B-Cell survival factors-APRIL and BAFF-in myasthenia gravis. J Neuroimmunol 178:161-166 (Pubitemid 44316862)
- (2006) Journal of Neuroimmunology , vol.178 , Issue.1-2 , pp. 161-166
- Thangarajh, M.¹ Masterman, T.² Helgeland, L.³ Rot, U.⁴ Jonsson, M.V.⁵ Eide, G.E.⁶ Pirskanen, R.⁷ Hillert, J.⁸ Jonsson, R.⁹

6
- 47549101395
- Serum BAFF expression in patients with myasthenia gravis
- Kim JY, Yang Y, Moon JS, Lee EY, So SH, Lee HS, Park KD, Choi YC (2008) Serum BAFF expression in patients with myasthenia gravis. J Neuroimmunol 199:151-154
- (2008) J Neuroimmunol , vol.199 , pp. 151-154
- Kim, J.Y.¹ Yang, Y.² Moon, J.S.³ Lee, E.Y.⁴ So, S.H.⁵ Lee, H.S.⁶ Park, K.D.⁷ Choi, Y.C.⁸

7
- 54049132513
- A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis
- Ragheb S, Lisak R, Lewis R, Van Stavern G, Gonzales F, Simon K (2008) A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis. Arch Neurol 65:1358-1362
- (2008) Arch Neurol , vol.65 , pp. 1358-1362
- Ragheb, S.¹ Lisak, R.² Lewis, R.³ Van Stavern, G.⁴ Gonzales, F.⁵ Simon, K.⁶

8
- 33750526860
- B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time
- DOI 10.1177/0961203306071871
- Becker-Merok A, Nikolaisen C, Nossent HC (2006) B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 15:570-576 (Pubitemid 44661743)
- (2006) Lupus , vol.15 , Issue.9 , pp. 570-576
- Becker-Merok, A.¹ Nikolaisen, C.² Nossent, H.C.³

9
- 33845864446
- High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura
- DOI 10.1111/j.1365-2141.2006.06431.x
- Emmerich F, Bal G, Barakat A, Milz J, Mühle C, Martinez- Gamboa L, Dörner T, Salama A (2006) High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol 136:309-314 (Pubitemid 46020761)
- (2007) British Journal of Haematology , vol.136 , Issue.2 , pp. 309-314
- Emmerich, F.¹ Bal, G.² Barakat, A.³ Milz, J.⁴ Muhle, C.⁵ Martinez-Gamboa, L.⁶ Dorner, T.⁷ Salama, A.⁸

10
- 79953164263
- The kaleidoscope of glucorticoid effects on immune system
- Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, Ramonda R, Iaccarino L, Doria A (2011) The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10:305-310
- (2011) Autoimmun Rev , vol.10 , pp. 305-310
- Zen, M.¹ Canova, M.² Campana, C.³ Bettio, S.⁴ Nalotto, L.⁵ Rampudda, M.⁶ Ramonda, R.⁷ Iaccarino, L.⁸ Doria, A.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.